Bimanual Motor Skill Learning in Acute Stroke

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-90
SponsorUniversity Hospital of Mont-Godinne

About this trial

The subacute phase of stroke provides a window into how a lesion perturbs sensorimotor functions prior to reorganisation driven by plasticity and neurorehabilitation. The recovery from motor impairment has been extensively studied, but it is currently unknown whether motor skill learning (MSkL) is enhanced or impaired during acute stroke, especially bimanual motor skill learning (bim-MSkL), which likely requires more motor-attentional-cognitive resources than unimanual MSkL.

The goals of this project are: to determine the neural substrates critical to achieve proximal and distal bimanual motor skill learning (bim-MSkL) by specifying whether (sub)acute stroke to different brain areas (cortical and subcortical) induce specific deficits in bimanual and/or distal bim-MSkL, which behavioral components are involved in bim-MSkL, and whether damage to the motor, sensory and inter-hemispheric pathways specifically impairs proximal and/or distal bim-MSkL.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

acute stroke (< 21 days)

aged 18-90 years

with a demonstrated stroke (ischemic or hemorrhagic) lesion on brain imaging

Disqualifiers

" classical " contre-indication to MRI (non-MR-compatible pacemaker, pregnancy, non-MR-compatible implanted devices, claustrophobia, etc ...)

difficulty in understanding or executing commands

drug/alcohol abuse

severe aphasia / cognitive deficits interfering with study

Trial design

Design model

Parallel

Treatments tested in this trial

  • REAplan®

    Device

    motor skill learning with the REAplan® rehabilitation robot, to be performed with both arms

  • Dextrain Manipulandum®

    Device

    motor skill learning with the Dextrain Manipulandum® dexterity tool to be performed with both hands

Treatment groups

160 Participants
are divided into 2 treatment groups
Group A: Bimanual Circuit version 1Experimental treatment 2 interventions
Group B: Bimanual Circuit version 2Experimental treatment 2 interventions

Trial outcomes

Primary outcomes

1

bimanual Speed/Accuracy Trade-off (bi-SAT), bimanual Speed/Accuracy Trade-off measured by the REAplan® robot

bimanual Speed/Accuracy Trade-off: mathematical computation of the relationship between speed and accuracy

Time frame
change between baseline (Day 1) and after training (Day 3)
2

bimanual Coordination factor (bi-CO), bimanual Coordination factor measured by the REAplan® robot

bimanual Coordination factor, mathematical measure of the phase coherence between speeds of both arms

Time frame
change between baseline (Day 1) and after training (Day 3)
3

bi-Force, bimanual force measured by the REAplan® robot

bimanual forces, forces exerted in the wrong direction by each arm (Newtons)

Time frame
change between baseline (Day 1) and after training (Day 3)
4

Root Mean Square Error (RMSE), bimanual root mean square error measured by the Dextrain Manipulandum

Tracking error between the actual applied force and the target force

Time frame
change between baseline (Day 1) and after training (Day 3)

Secondary outcomes

1

Reaction time measured by the Dextrain Manipulandum

time between the target appearance and when the force applied exceeds threshold

Time frame
change between baseline (Day 1) and after training (Day 3)
2

Rise time measured by the Dextrain Manipulandum

time between the reaction time and reaching the plateau

Time frame
change between baseline (Day 1) and after training (Day 3)
3

Coactivation measured by the Dextrain Manipulandum

binary measure of unasked fingers activated above the force threshold

Time frame
change between baseline (Day 1) and after training (Day 3)
4

Hold time measured by the Dextrain Manipulandum

time of plateau maintenance

Time frame
change between baseline (Day 1) and after training (Day 3)

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.